摘要
目的:分析、探讨精神类药品在预防、治疗小儿热性惊厥中的应用情况,试评价其有效性、安全性及经济性,为临床合理用药提供依据。方法:回顾性分析239例热性惊厥(FS)患儿的一般资料、不良反应发生率、惊厥复发情况和治疗费用。结果:239例热性惊厥患儿中单纯型热性惊厥(SFS)患儿预防用药率为92.4%,复杂型热性惊厥(complicated feverseizures,CFS)患儿预防用药率为100%。主要使用药物为巴比妥类药物。苯巴比妥与地西泮在防治小儿热性惊厥的有效率、治疗费用方面差异无统计学意义(P>0.05);但是,地西泮较苯巴比妥不良反应发生率、惊厥复发率低,差异有统计学意义(P<0.05)。结论:239例热性惊厥患儿中,92.4%的单纯型热性惊厥患儿预防用药率偏高,止惊、预防用药基本合理。
Objective: To determine the use situation of anticonvulsant drugs in pediatric outpatients of Weihai Municipal Hospital in 2015,and analyze their effectiveness,safety and economy so as to provide a basis for clinical rational medication. Methods:The general information of 239 children with fever seizures( FS),the incidence rate of adverse drug reactions,FS recurrence and the costs were retrospectively analyzed. Results: Among the 239 children,the rates of preventive medications in simple fever seizures( SFS) and complicated fever seizures( CFS) were 92.4% and 100%,respectively. The Barbiturates were commonly used. There were no statistical differences in the effective rate and treatment costs of Diazepam and Phenobarbital in the treatment of the children with FS( P>0.05); however,the incidence rate of adverse drug reactions and FS recurrence rate of Diazepam were lower than those of Phenobarbital,and the differences were statistically significant( P<0.05). Conclusions: Among the 239 children with FS,the rate of preventive medications in SFS is high,but the choice of the anticonvulsant drugs in the treatment and prevention of convulsions isreasonable basically.
出处
《中国民康医学》
2016年第21期55-57,共3页
Medical Journal of Chinese People’s Health
关键词
儿科门诊
热性惊厥
抗惊厥药物
用药安全
Pediatric Outpatient
Fever seizures
Anticonvulsant drug
Drug use safety